{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:01:01Z","timestamp":1761897661565,"version":"3.37.3"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T00:00:00Z","timestamp":1641254400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T00:00:00Z","timestamp":1641254400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873037"],"award-info":[{"award-number":["81873037"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2018ZX01031301"],"award-info":[{"award-number":["2018ZX01031301"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2018YFC1704502"],"award-info":[{"award-number":["2018YFC1704502"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>We investigate the chemical basis and mechanism of angiogenesis regulation by a multicomponent Chinese medicine Danhong injection (DHI).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>DHI was fractionated and screened for angiogenesis activities by in vitro tube formation and migration assays. The composition of DHI components was determined by UPLC. The effects of the main active monomers on angiogenesis-related gene and protein expression in endothelial cells were determined by qPCR and Western blotting analyses. Mouse hind limb ischemia and tumor implant models were used to verify the angiogenesis effects in vivo by Laser Doppler and bioluminescent imaging, respectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Two distinct chemical components, one promoting (pro-angiogenic, PAC) and the other inhibiting (anti-angiogenic, AAC) angiogenesis, were identified in DHI. PAC enhanced angiogenesis and improved recovery of ischemic limb perfusion while AAC reduced Lewis lung carcinoma growth in vivo in VEGFR-2-Luc mice. Among the PAC or AAC monomers, caffeic acid and rosmarinic acid upregulated TSP1 expression and downregulated KDR and PECAM expression. Caffeic acid and rosmarinic acid significantly decreased while protocatechuic aldehyde increased CXCR4 expression, which are consistent with their differential effects on EC migration.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>DHI is capable of bi-directional regulation of angiogenesis in disease-specific manner. The pro-angiogenesis activity of DHI promotes the repair of ischemic vascular injury, whereas the anti-angiogenesis activity inhibits tumor growth. The active pro- and anti-angiogenesis activities are composed of unique chemical combinations that differentially regulate angiogenesis-related gene networks.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13020-021-00557-5","type":"journal-article","created":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T08:02:50Z","timestamp":1641283370000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Differential action of pro-angiogenic and anti-angiogenic components of Danhong injection in ischemic vascular disease or tumor models"],"prefix":"10.1186","volume":"17","author":[{"given":"Shuang","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongrong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenzuo","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haixin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zihao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiechan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John Owoicho","family":"Orgah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuefei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiumei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3197-7936","authenticated-orcid":false,"given":"Yan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,4]]},"reference":[{"issue":"6191","key":"557_CR1","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1126\/science.1257071","volume":"344","author":"LB Rivera","year":"2014","unstructured":"Rivera LB, Bergers G. Angiogenesis. Targeting vascular sprouts. Science. 2014;344(6191):1449\u201350.","journal-title":"Science"},{"issue":"9792","key":"557_CR2","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/S0140-6736(11)60894-5","volume":"378","author":"AM Shah","year":"2011","unstructured":"Shah AM, Mann DL. In search of new therapeutic targets and strategies for heart failure: recent advances in basic science. Lancet. 2011;378(9792):704\u201312.","journal-title":"Lancet"},{"issue":"8","key":"557_CR3","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/nrcardio.2009.103","volume":"6","author":"AM van der Laan","year":"2009","unstructured":"van der Laan AM, Piek JJ, van Royen N. Targeting angiogenesis to restore the microcirculation after reperfused MI. Nat Rev Cardiol. 2009;6(8):515\u201323.","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"557_CR4","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12943-019-0974-6","volume":"18","author":"M Yi","year":"2019","unstructured":"Yi M, Jiao D, Qin S, Chu Q, Wu K, Li A. Synergistic effect of immune checkpoint blockade and anti-angiogenesis in cancer treatment. Mol Cancer. 2019;18(1):60.","journal-title":"Mol Cancer"},{"issue":"23","key":"557_CR5","doi-asserted-by":"publisher","first-page":"10637","DOI":"10.1158\/0008-5472.CAN-05-3473","volume":"65","author":"A Albini","year":"2005","unstructured":"Albini A, Tosetti F, Benelli R, Noonan DM. Tumor inflammatory angiogenesis and its chemoprevention. Cancer Res. 2005;65(23):10637\u201341.","journal-title":"Cancer Res"},{"issue":"1","key":"557_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13045-019-0718-5","volume":"12","author":"S Qin","year":"2019","unstructured":"Qin S, Li A, Yi M, Yu S, Zhang M, Wu K. Recent advances on anti-angiogenesis receptor tyrosine kinase inhibitors in cancer therapy. J Hematol Oncol. 2019;12(1):27.","journal-title":"J Hematol Oncol"},{"issue":"10","key":"557_CR7","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1161\/01.CIR.0000140676.88412.CF","volume":"110","author":"S Sengupta","year":"2004","unstructured":"Sengupta S, Toh SA, Sellers LA, Skepper JN, Koolwijk P, Leung HW, et al. Modulating angiogenesis: the yin and the yang in ginseng. Circulation. 2004;110(10):1219\u201325.","journal-title":"Circulation"},{"issue":"4","key":"557_CR8","first-page":"241","volume":"14","author":"HX Liu","year":"2016","unstructured":"Liu HX, Wang Y, Lu Q, Yang MZ, Fan GW, Karas RH, et al. Bidirectional regulation of angiogenesis by phytoestrogens through estrogen receptor-mediated signaling networks. Chin J Nat Med. 2016;14(4):241\u201354.","journal-title":"Chin J Nat Med"},{"issue":"23","key":"557_CR9","first-page":"3413","volume":"44","author":"RG Chen","year":"2013","unstructured":"Chen RG, Xu H, He Y, Zhu S. Research progress on pro- or anti-angiogenic effects of Chinese materia medica fomulas and their active components. Chin Trad Herb Drugs. 2013;44(23):3413\u201321.","journal-title":"Chin Trad Herb Drugs"},{"issue":"2","key":"557_CR10","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jphs.2016.09.003","volume":"132","author":"W Cao","year":"2016","unstructured":"Cao W, Hu C, Wu L, Xu L, Jiang W. Rosmarinic acid inhibits inflammation and angiogenesis of hepatocellular carcinoma by suppression of NF-kappaB signaling in H22 tumor-bearing mice. J Pharmacol Sci. 2016;132(2):131\u20137.","journal-title":"J Pharmacol Sci"},{"key":"557_CR11","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.phrs.2018.11.006","volume":"139","author":"X Feng","year":"2019","unstructured":"Feng X, Li Y, Wang Y, Li L, Little PJ, Xu SW, et al. Danhong injection in cardiovascular and cerebrovascular diseases: pharmacological actions, molecular mechanisms, and therapeutic potential. Pharmacol Res. 2019;139:62\u201375.","journal-title":"Pharmacol Res"},{"key":"557_CR12","doi-asserted-by":"publisher","first-page":"104654","DOI":"10.1016\/j.phrs.2020.104654","volume":"153","author":"JO Orgah","year":"2020","unstructured":"Orgah JO, He S, Wang Y, Jiang M, Wang Y, Orgah EA, et al. Pharmacological potential of the combination of Salvia miltiorrhiza (Danshen) and Carthamus tinctorius (Honghua) for diabetes mellitus and its cardiovascular complications. Pharmacol Res. 2020;153:104654.","journal-title":"Pharmacol Res"},{"issue":"1","key":"557_CR13","doi-asserted-by":"publisher","first-page":"15427","DOI":"10.1038\/s41598-017-14692-3","volume":"7","author":"M Lyu","year":"2017","unstructured":"Lyu M, Yan CL, Liu HX, Wang TY, Shi XH, Liu JP, et al. Network pharmacology exploration reveals endothelial inflammation as a common mechanism for stroke and coronary artery disease treatment of Danhong injection. Sci Rep. 2017;7(1):15427.","journal-title":"Sci Rep"},{"issue":"5","key":"557_CR14","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1097\/FJC.0000000000000067","volume":"63","author":"Y Chen","year":"2014","unstructured":"Chen Y, Liu M, Zhao T, Zhao B, Jia L, Zhu Y, et al. Danhong injection inhibits the development of atherosclerosis in both Apoe(-)\/(-) and Ldlr(-)\/(-) mice. J Cardiovasc Pharmacol. 2014;63(5):441\u201352.","journal-title":"J Cardiovasc Pharmacol"},{"key":"557_CR15","doi-asserted-by":"publisher","first-page":"11219","DOI":"10.1038\/srep11219","volume":"5","author":"M Liu","year":"2015","unstructured":"Liu M, Pan Q, Chen Y, Yang X, Zhao B, Jia L, et al. Administration of Danhong Injection to diabetic db\/db mice inhibits the development of diabetic retinopathy and nephropathy. Sci Rep. 2015;5:11219.","journal-title":"Sci Rep"},{"issue":"1","key":"557_CR16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1159\/000486735","volume":"43","author":"J Owoicho Orgah","year":"2018","unstructured":"Owoicho Orgah J, Wang M, Yang X, Wang Z, Wang D, Zhang Q, et al. Danhong injection protects against hypertension-induced renal injury via down-regulation of myoglobin expression in spontaneously hypertensive rats. Kidney Blood Press Res. 2018;43(1):12\u201324.","journal-title":"Kidney Blood Press Res"},{"issue":"8","key":"557_CR17","doi-asserted-by":"publisher","first-page":"e105412","DOI":"10.1371\/journal.pone.0105412","volume":"9","author":"M Jiang","year":"2014","unstructured":"Jiang M, Jiao Y, Wang Y, Xu L, Wang M, Zhao B, et al. Quantitative profiling of polar metabolites in herbal medicine injections for multivariate statistical evaluation based on independence principal component analysis. PloS ONE. 2014;9(8):e105412.","journal-title":"PloS ONE"},{"issue":"2","key":"557_CR18","first-page":"147","volume":"14","author":"QQ Zhang","year":"2016","unstructured":"Zhang QQ, Dong X, Liu XG, Gao W, Li P, Yang H. Rapid separation and identification of multiple constituents in Danhong Injection by ultra-high performance liquid chromatography coupled to electrospray ionization quadrupole time-of-flight tandem mass spectrometry. Chin J Nat Med. 2016;14(2):147\u201360.","journal-title":"Chin J Nat Med"},{"issue":"5","key":"557_CR19","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1097\/FJC.0b013e3182a29657","volume":"62","author":"D Wang","year":"2013","unstructured":"Wang D, Fan G, Wang Y, Liu H, Wang B, Dong J, et al. Vascular reactivity screen of Chinese medicine danhong injection identifies Danshensu as a NO-independent but PGI2-mediated relaxation factor. J Cardiovasc Pharmacol. 2013;62(5):457\u201365.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"1","key":"557_CR20","doi-asserted-by":"publisher","first-page":"4308","DOI":"10.1038\/s41598-017-04661-1","volume":"7","author":"X Yang","year":"2017","unstructured":"Yang X, Orgah J, Wang D, Fan G, Jingyang H, Han J, et al. Danhong injection reduces vascular remodeling and up-regulates the Kallikrein-kinin system in spontaneously hypertensive rats. Sci Rep. 2017;7(1):4308.","journal-title":"Sci Rep"},{"key":"557_CR21","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.brainres.2016.04.046","volume":"1642","author":"M Yang","year":"2016","unstructured":"Yang M, Orgah J, Zhu J, Fan G, Han J, Wang X, et al. Danhong injection attenuates cardiac injury induced by ischemic and reperfused neuronal cells through regulating arginine vasopressin expression and secretion. Brain Res. 2016;1642:516\u201323.","journal-title":"Brain Res"},{"issue":"4","key":"557_CR22","first-page":"375","volume":"37","author":"JO Orgah","year":"2019","unstructured":"Orgah JO, Ren J, Liu X, Orgah EA, Gao XM, Zhu Y. Danhong injection facilitates recovery of post-stroke motion deficit via Parkin-enhanced mitochondrial function. Restor Neurol Neurosci. 2019;37(4):375\u201395.","journal-title":"Restor Neurol Neurosci"},{"key":"557_CR23","doi-asserted-by":"publisher","first-page":"692","DOI":"10.3389\/fphar.2018.00692","volume":"9","author":"JO Orgah","year":"2018","unstructured":"Orgah JO, Yu J, Zhao T, Wang L, Yang M, Zhang Y, et al. Danhong injection reversed cardiac abnormality in brain-heart syndrome via local and remote beta-adrenergic receptor signaling. Front Pharmacol. 2018;9:692.","journal-title":"Front Pharmacol"},{"issue":"12","key":"557_CR24","doi-asserted-by":"publisher","first-page":"e0167305","DOI":"10.1371\/journal.pone.0167305","volume":"11","author":"S He","year":"2016","unstructured":"He S, Zhao T, Guo H, Meng Y, Qin G, Goukassian DA, et al. Coordinated activation of VEGF\/VEGFR-2 and PPARdelta pathways by a multi-component chinese medicine DHI accelerated recovery from peripheral arterial disease in type 2 diabetic mice. PLoS ONE. 2016;11(12):e0167305.","journal-title":"PLoS ONE"},{"key":"557_CR25","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.3389\/fphar.2019.01080","volume":"10","author":"S He","year":"2019","unstructured":"He S, Guo H, Zhao T, Meng Y, Chen R, Ren J, et al. A defined combination of four active principles from the danhong injection is necessary and sufficient to accelerate EPC-mediated vascular repair and local angiogenesis. Front Pharmacol. 2019;10:1080.","journal-title":"Front Pharmacol"},{"key":"557_CR26","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.jep.2016.10.025","volume":"194","author":"J Chen","year":"2016","unstructured":"Chen J, Cao W, Asare PF, Lv M, Zhu Y, Li L, et al. Amelioration of cardiac dysfunction and ventricular remodeling after myocardial infarction by danhong injection are critically contributed by anti-TGF-beta-mediated fibrosis and angiogenesis mechanisms. J Ethnopharmacol. 2016;194:559\u201370.","journal-title":"J Ethnopharmacol"},{"key":"557_CR27","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3389\/fphar.2017.00361","volume":"8","author":"T Zhao","year":"2017","unstructured":"Zhao T, Chang L, Zhang B, Lu M, Wang X, Orgah JO, et al. Specific combination of salvianolic acids as core active ingredients of danhong injection for treatment of arterial thrombosis and its derived dry gangrene. Front Pharmacol. 2017;8:361.","journal-title":"Front Pharmacol"},{"key":"557_CR28","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.phymed.2018.06.009","volume":"49","author":"J Fu","year":"2018","unstructured":"Fu J, Yu J, Chen J, Xu H, Luo Y, Lu H. In vitro inhibitory properties of sesquiterpenes from Chloranthus serratus on cell motility via down-regulation of LIMK1 activation in human breast cancer. Phytomedicine. 2018;49:23\u201331.","journal-title":"Phytomedicine"},{"issue":"9","key":"557_CR29","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1096\/fj.02-0172fje","volume":"17","author":"SE Michaud","year":"2003","unstructured":"Michaud SE, Menard C, Guy LG, Gennaro G, Rivard A. Inhibition of hypoxia-induced angiogenesis by cigarette smoke exposure: impairment of the HIF-1alpha\/VEGF pathway. FASEB J. 2003;17(9):1150\u20132.","journal-title":"FASEB J"},{"issue":"2","key":"557_CR30","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1182\/blood-2003-06-1820","volume":"103","author":"N Zhang","year":"2004","unstructured":"Zhang N, Fang Z, Contag PR, Purchio AF, West DB. Tracking angiogenesis induced by skin wounding and contact hypersensitivity using a Vegfr2-luciferase transgenic mouse. Blood. 2004;103(2):617\u201326.","journal-title":"Blood"},{"issue":"3","key":"557_CR31","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1093\/cvr\/cvt067","volume":"98","author":"R Basu","year":"2013","unstructured":"Basu R, Lee J, Morton JS, Takawale A, Fan D, Kandalam V, et al. TIMP3 is the primary TIMP to regulate agonist-induced vascular remodelling and hypertension. Cardiovasc Res. 2013;98(3):360\u201371.","journal-title":"Cardiovasc Res"},{"issue":"4","key":"557_CR32","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s10495-014-1076-y","volume":"20","author":"JH Qi","year":"2015","unstructured":"Qi JH, Anand-Apte B. Tissue inhibitor of metalloproteinase-3 (TIMP3) promotes endothelial apoptosis via a caspase-independent mechanism. Apoptosis. 2015;20(4):523\u201334.","journal-title":"Apoptosis"},{"key":"557_CR33","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/srep00788","volume":"2","author":"R Bienes-Martinez","year":"2012","unstructured":"Bienes-Martinez R, Ordonez A, Feijoo-Cuaresma M, Corral-Escariz M, Mateo G, Stenina O, et al. Autocrine stimulation of clear-cell renal carcinoma cell migration in hypoxia via HIF-independent suppression of thrombospondin-1. Sci Rep. 2012;2:788.","journal-title":"Sci Rep"},{"issue":"4","key":"557_CR34","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/74651","volume":"6","author":"P Carmeliet","year":"2000","unstructured":"Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med. 2000;6(4):389\u201395.","journal-title":"Nat Med"},{"issue":"3","key":"557_CR35","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1042\/CS20140714","volume":"129","author":"S Park","year":"2015","unstructured":"Park S, Sorenson CM, Sheibani N. PECAM-1 isoforms, eNOS and endoglin axis in regulation of angiogenesis. Clin Sci. 2015;129(3):217\u201334.","journal-title":"Clin Sci"},{"issue":"1","key":"557_CR36","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/jbmr.2318","volume":"30","author":"Y Kawakami","year":"2015","unstructured":"Kawakami Y, Ii M, Matsumoto T, Kuroda R, Kuroda T, Kwon SM, et al. SDF-1\/CXCR4 axis in Tie2-lineage cells including endothelial progenitor cells contributes to bone fracture healing. J Bone Miner Res. 2015;30(1):95\u2013105.","journal-title":"J Bone Miner Res"},{"issue":"9","key":"557_CR37","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1161\/01.CIR.0000055313.77510.22","volume":"107","author":"J Yamaguchi","year":"2003","unstructured":"Yamaguchi J, Kusano KF, Masuo O, Kawamoto A, Silver M, Murasawa S, et al. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation. 2003;107(9):1322\u20138.","journal-title":"Circulation"},{"issue":"3","key":"557_CR38","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1093\/cvr\/cvq207","volume":"88","author":"L Chen","year":"2010","unstructured":"Chen L, Wu F, Xia WH, Zhang YY, Xu SY, Cheng F, et al. CXCR4 gene transfer contributes to in vivo reendothelialization capacity of endothelial progenitor cells. Cardiovasc Res. 2010;88(3):462\u201370.","journal-title":"Cardiovasc Res"},{"issue":"4","key":"557_CR39","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1159\/000487572","volume":"45","author":"F Li","year":"2018","unstructured":"Li F, Fan XX, Chu C, Zhang Y, Kou JP, Yu BY. A strategy for optimizing the combination of active components based on chinese medicinal formula Sheng-Mai-San for myocardial ischemia. Cell Physiol Biochem. 2018;45(4):1455\u201371.","journal-title":"Cell Physiol Biochem"},{"issue":"6","key":"557_CR40","doi-asserted-by":"publisher","first-page":"e40262","DOI":"10.1371\/journal.pone.0040262","volume":"7","author":"JJ Lu","year":"2012","unstructured":"Lu JJ, Pan W, Hu YJ, Wang YT. Multi-target drugs: the trend of drug research and development. PloS ONE. 2012;7(6):e40262.","journal-title":"PloS ONE"},{"issue":"3","key":"557_CR41","doi-asserted-by":"publisher","first-page":"e00149","DOI":"10.1002\/prp2.149","volume":"3","author":"J Foucquier","year":"2015","unstructured":"Foucquier J, Guedj M. Analysis of drug combinations: current methodological landscape. Pharmacol Res Perspect. 2015;3(3):e00149.","journal-title":"Pharmacol Res Perspect"}],"container-title":["Chinese Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-021-00557-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13020-021-00557-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-021-00557-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T08:13:40Z","timestamp":1666599220000},"score":1,"resource":{"primary":{"URL":"https:\/\/cmjournal.biomedcentral.com\/articles\/10.1186\/s13020-021-00557-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,4]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["557"],"URL":"https:\/\/doi.org\/10.1186\/s13020-021-00557-5","relation":{},"ISSN":["1749-8546"],"issn-type":[{"type":"electronic","value":"1749-8546"}],"subject":[],"published":{"date-parts":[[2022,1,4]]},"assertion":[{"value":"8 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the experiments were reviewed and approved by the TJAB Animal Experiment Ethical Committee (TJAB-JY-2011-002). The experiments were conducted in accord with the guidelines for the use of animal experiments at Tianjin University of Traditional Chinese Medicine.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4"}}